M&A Deal Summary |
|
|---|---|
| Date | 2020-03-07 |
| Target | ThermaCare |
| Sector | Consumer Products |
| Buyer(s) | Angelini |
| Sellers(s) | Wyeth |
| Deal Type | Divestiture |
SEARCH BY
Angelini S.p.a. is a European player in innovation, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. Angelini S.p.a. pledge to successfully develop distinctive treatments for Mental Health conditions and Pain while selectively preserving the leading position in the Consumer Health segment.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Consumer Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: Georgia M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-03-07 |
GlaxoSmithKline - ThermaCare Global Business
Brentford, United Kingdom GlaxoSmithKline plc's ThermaCare Global Business uses patented technology that produces real heat to help the body rebuild damaged tissue and accelerate healing. ThermaCare® products are formulated for: Lower Back & Hip, Neck, Wrist & Shoulder, Knee & Elbow, Multi-Purpose Muscle, Multi-Purpose Joint, and Menstrual. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-05 |
Arvelle Therapeutics
Zug, Switzerland Arvelle Therapeutics is an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders. Arvelle Therapeutics was founded in 2019 and is based in Zug, Switzerland. |
Buy | $960M |
| Category | Company |
|---|---|
| Founded | 1860 |
| Sector | Life Science |
| Employees | 50,000 |
| Revenue | 22.4B USD (2008) |
Wyeth is a research-driven pharmaceutical and health care products company. It discovers, develops, manufactures and markets pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Consumer Products M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 4 of 4 |
| State: Georgia M&A | 1 of 1 |
| Country: United States M&A | 3 of 3 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-18 |
Thiakis Limited
London, United Kingdom Thiakis is the developer of a treatment of severe obesity and comorbidities, including diabetes and heart disease. |
Buy | $150M |
